Wei Dai: Checkpoint Responses in Cancer Therapy - new book
ISBN: 9781617378478
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anti… More...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Wei Dai, Books, Health and Well Being, Checkpoint Responses in Cancer Therapy Books>Health and Well Being, Springer-Verlag/Sci-Tech/Trade<
Indigo.ca
new Free shipping on orders above $25. Shipping costs:zzgl. Versandkosten., plus shipping costs Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters - new book
ISBN: 9781617378478
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug developm… More...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. | Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters Books > Health > Ailments & Diseases > Cancer P10178, Wei Dai<
Indigo.ca
new in stock. Shipping costs:zzgl. Versandkosten., plus shipping costs Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Checkpoint Responses in Cancer Therapy - Paperback
2010, ISBN: 9781617378478
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle proc… More...
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Buch (fremdspr.) Taschenbuch, Springer, 19.11.2010, Springer, 2010<
Thalia.de
Nr. 25603390. Shipping costs:, Lieferbar in 1 - 2 Wochen, DE. (EUR 0.00) Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer dru… More...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Books > Health > Ailments & Diseases > Cancer List_Books<
Indigo.ca
new in stock. Shipping costs:zzgl. Versandkosten., plus shipping costs Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Wei Dai: Checkpoint Responses in Cancer Therapy - Paperback
ISBN: 9781617378478
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their … More...
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs., Oncology<
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anti… More...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Wei Dai, Books, Health and Well Being, Checkpoint Responses in Cancer Therapy Books>Health and Well Being, Springer-Verlag/Sci-Tech/Trade<
- new Free shipping on orders above $25. Shipping costs:zzgl. Versandkosten., plus shipping costs
Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters - new book
ISBN: 9781617378478
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug developm… More...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. | Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters Books > Health > Ailments & Diseases > Cancer P10178, Wei Dai<
new in stock. Shipping costs:zzgl. Versandkosten., plus shipping costs
Checkpoint Responses in Cancer Therapy - Paperback
2010
ISBN: 9781617378478
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle proc… More...
Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Buch (fremdspr.) Taschenbuch, Springer, 19.11.2010, Springer, 2010<
Nr. 25603390. Shipping costs:, Lieferbar in 1 - 2 Wochen, DE. (EUR 0.00)
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer dru… More...
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today''s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book''s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. Books > Health > Ailments & Diseases > Cancer List_Books<
new in stock. Shipping costs:zzgl. Versandkosten., plus shipping costs
Wei Dai: Checkpoint Responses in Cancer Therapy - Paperback
ISBN: 9781617378478
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their … More...
Paperback, [PU: Humana Press Inc.], Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs., Oncology<
1As some platforms do not transmit shipping conditions to us and these may depend on the country of delivery, the purchase price, the weight and size of the item, a possible membership of the platform, a direct delivery by the platform or via a third-party provider (Marketplace), etc., it is possible that the shipping costs indicated by euro-book.co.uk / euro-book.co.uk do not correspond to those of the offering platform.
Extensive research has uncovered a set of molecular surveillance mechanisms - commonly called "checkpoints" - which tightly monitor cell-cycle processes. Today's anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book's distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis.
Details of the book - Checkpoint Responses in Cancer Therapy by Wei Dai Paperback | Indigo Chapters
EAN (ISBN-13): 9781617378478 ISBN (ISBN-10): 161737847X Paperback Publishing year: 2010 Publisher: Wei Dai 328 Pages Weight: 0,494 kg Language: eng/Englisch
Book in our database since 2012-03-14T21:55:53+00:00 (London) Detail page last modified on 2022-10-07T18:29:45+01:00 (London) ISBN/EAN: 9781617378478
ISBN - alternate spelling: 1-61737-847-X, 978-1-61737-847-8 Alternate spelling and related search-keywords: Book author: wei Book title: checkpoint
Information from Publisher
Author: Wei Dai Title: Cancer Drug Discovery and Development; Checkpoint Responses in Cancer Therapy Publisher: Humana; Humana Press 314 Pages Publishing year: 2010-11-19 Totowa; NJ; US Printed / Made in Language: English 213,99 € (DE) 219,99 € (AT) 236,00 CHF (CH) POD XIV, 314 p. 33 illus., 3 illus. in color.
BC; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; DNA; apoptosis; biotechnology; cancer; cancer research; cancer therapy; cell; cell cycle; checkpoint; chemotherapy; development; drug; drug design; drug development; research; Cancer Biology; Pharmacology; Pharmakologie; BB
RB-Pathway.- Targeting the p53/MDM2 Pathway for Cancer Therapy.- DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer.- Targeting ATM/ATR in the DNA Damage Checkpoint.- Compounds that Abrogate the G2 Checkpoint.- CDK Inhibitors as Anticancer Agents.- CHFR as a Potential Anticancer Target.- Antimicrotubule Agents.- Kinesin Motor Inhibitors as Effective Anticancer Drugs.- Targeting the Spindle Checkpoint in Cancer Chemotherapy.- Antiproliferation Inhibitors Targeting Aurora Kinases.- Plks as Novel Targets for Cancer Drug Design.- Do Histone Deacetylase Inhibitors Target Cell Cycle Checkpoints that Monitor Heterochromatin Structure?. First book to summarize recent advances in identifying components of cell-cycle checkpoints and validating the use of checkpoint proteins as targets for the development of anticancer drugs Distinguished authors write on topics that range from the molecular players affecting DNA synthesis and the response to DNA damage, to advances in the identification of inhibitors for individual mitotic kinases Offers a summary of their findings for researchers in the pharmaceutical and biotechnology industries Valuable resource for cancer researchers studying of cell-cycle regulation, signal transduction, and apoptosis
More/other books that might be very similar to this book